Answer
UK oral products are licensed for specified forms of myelofibrosis, hydroxyurea-resistant or intolerant polycythaemia vera, and acute or chronic graft-versus-host disease with an inadequate corticosteroid response.
Sources for this answer
- Jakavi 5mg, 10mg, 15mg and 20mg Tablets — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.